Literature DB >> 17893849

High-throughput microRNAome analysis in human germ cell tumours.

A J M Gillis1, H J Stoop, R Hersmus, J W Oosterhuis, Y Sun, C Chen, S Guenther, J Sherlock, I Veltman, J Baeten, P J van der Spek, P de Alarcon, L H J Looijenga.   

Abstract

Testicular germ cell tumours (GCTs) of adolescents and adults can be subdivided into seminomas (referred to as dysgerminomas of the ovary) and non-seminomas, all referred to as type II GCTs. They originate from carcinoma in situ (CIS), being the malignant counterparts of primordial germ cells (PGCs)/gonocytes. The invasive components mimic embryogenesis, including the stem cell component embryonal carcinoma (EC), the somatic lineage teratoma (TE), and the extra-embryonic tissues yolk sac tumour (YST) and choriocarcinoma (CH). The other type is the so-called spermatocytic seminomas (SS, type III GCT), composed of neoplastic primary spermatocytes. We reported previously that the miRNAs hsa-miR 371-373 cluster is involved in overruling cellular senescence induced by oncogenic stress, allowing cells to become malignant. Here we report the first high-throughput screen of 156 microRNAs in a series of type II and III GCTs (n = 69, in duplicate) using a quantitative PCR-based approach. After normalization to allow inter-sample analysis, the technical replicates clustered together, and the previous hsa-miRNA 371-373 cluster finding was confirmed. Unsupervised cluster analysis demonstrated that the cell lines are different from the in vivo samples. The in vivo samples, both normal and malignant, clustered predominantly based on their maturation status. This parallels normal embryogenesis, rather than chromosomal anomalies in the tumours. miRNAs within a single cluster showed a similar expression pattern, implying common regulatory mechanisms. Normal testicular tissue expressed most discriminating miRNAs at a higher level than SE and SS. Moreover, differentiated non-seminomas showed overexpression of discriminating miRNAs. These results support the model that miRNAs are involved in regulating differentiation of stem cells, retained in GCTs. Copyright 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893849     DOI: 10.1002/path.2230

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  83 in total

1.  Comprehensive microRNA expression profiling of the hematopoietic hierarchy.

Authors:  O I Petriv; F Kuchenbauer; A D Delaney; V Lecault; A White; D Kent; L Marmolejo; M Heuser; T Berg; M Copley; J Ruschmann; S Sekulovic; C Benz; E Kuroda; V Ho; F Antignano; T Halim; V Giambra; G Krystal; C J F Takei; A P Weng; J Piret; C Eaves; M A Marra; R K Humphries; C L Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-11       Impact factor: 11.205

2.  Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.

Authors:  Roger D Palmer; Matthew J Murray; Harpreet K Saini; Stijn van Dongen; Cei Abreu-Goodger; Balaji Muralidhar; Mark R Pett; Claire M Thornton; James C Nicholson; Anton J Enright; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

Review 3.  Concise review: MicroRNA expression in multipotent mesenchymal stromal cells.

Authors:  Uma Lakshmipathy; Ronald P Hart
Journal:  Stem Cells       Date:  2007-11-08       Impact factor: 6.277

4.  Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.

Authors:  Sharmila A Bapat; Victor Jin; Nicholas Berry; Curt Balch; Neeti Sharma; Nawneet Kurrey; Shu Zhang; Fang Fang; Xun Lan; Meng Li; Brian Kennedy; Robert M Bigsby; Tim H M Huang; Kenneth P Nephew
Journal:  Epigenetics       Date:  2010-11-01       Impact factor: 4.528

Review 5.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.

Authors:  Annika Schaefer; Carsten Stephan; Jonas Busch; George M Yousef; Klaus Jung
Journal:  Nat Rev Urol       Date:  2010-04-06       Impact factor: 14.432

Review 6.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

7.  MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Authors:  Z Bing; S R Master; J W Tobias; D A Baldwin; X W Xu; J E Tomaszewski
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

8.  Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.

Authors:  Hsei-Wei Wang; Yu-Hsuan Wu; Jui-Yu Hsieh; Muh-Lii Liang; Meng-En Chao; Da-Jung Liu; Ming-Ta Hsu; Tai-Tong Wong
Journal:  BMC Genomics       Date:  2010-02-24       Impact factor: 3.969

9.  Analysis of microRNA expression in the prepubertal testis.

Authors:  Gregory M Buchold; Cristian Coarfa; Jong Kim; Aleksandar Milosavljevic; Preethi H Gunaratne; Martin M Matzuk
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 10.  [Advances in basic research on testicular germ cell tumors : clinical implications].

Authors:  L H J Looijenga
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.